Company / R&D per Share
InMed Pharmaceuticals Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$7.22
FY2025
5-year range
$1.12 / $16.58
FY2022-FY2025
Trend
+543.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share changed +543% YoY in FY2025, a notable deviation from the 3-year average annual change of +140%.
Based on SEC 10-K filings.
7.22 in FY2025 with a 3-year CAGR of -24.2%.
Declined from $11.19 to $7.22 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -24.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 543.5% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.22 | +543.5% |
| FY2024 | $1.12 | -90.0% |
| FY2023 | $11.19 | -32.5% |
| FY2022 | $16.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026